New England Journal of Medicine · 2011 · 68 citations · 3 references
PharmacyPharmacoeconomicsPharmacologyHealth EconomicsGeneric Drug EvaluationPharmaceutical EconomicsPharmacoeconomic EvaluationPharmacoepidemiologyDrug Cost AnalysisGeneric Drug Acquisition CostsGeneric Drug MarketingGeneric Drug PricingPharmaceutical Cost AnalysisPharmaceutical Cost BurdenPharmacoeconomic ReviewPotential Economic Impact
Interview with Cynthia Jackevicius on generic drugs and health care costs. (10:33)Download Lipitor (atorvastatin) was the top-selling prescription drug in the United States in 2010, but its patent expired in June 2011, and the first generic version entered the market on November 30. What economic impact will the availability of generic atorvastatin have?
3
Masahiro Kaneshige, Hideyo Suzuki, Kumiko Kaneshige et al. · Proceedings of the National Academy of Sciences · 2001 · 191 citations · Full text
Medicine, Endocrinology, Genetics +16